Table 1.
PCR Array | qRT-PCR Validation | ||||
---|---|---|---|---|---|
Gene Name | Symbol | Fold changea | P-value | Fold change (± SE)a | P-value |
Heme oxygenase (decycling) 1 | HMOX1 | 2.9 | 0.01 | 4.159 ± 0.524 | <0.001 |
Interleukin 6 (interferon, beta 2) | IL6 | 9.7 | 2.2 E-5 | 46.555 ± 15.197 | 0.016 |
Lipopolysaccharide binding protein | LBP | 3.5 | 0.018 | 2.301 ± 0.171 | 0.001 |
Triggering receptor expressed on myeloid cells 1 | TREM1 | 115.2 | 0.0009 | 7.079 ±0.162 | <0.001 |
Prostaglandin-endoperoxide synthase 2b | PTGS2 | −1.2 | 0.59 | 7.677 ± 2.128 | 0.018 |
HTR-8 cells were treated with DMSO (0.1 % v/v; solvent control) or 10 μM TBBPA for 24 h. The Innate and Adaptive Immune Responses PCR Array (SABiosciences; Valencia, CA) was used to explore changes in gene expression as described in the “Materials and Methods” section. Fold changes and p-values are shown for the genes with significant changes compared to the solvent control.
Mean fold change relative to the solvent control. PCR Array: n= 4 experiments, qRT-PCR Validation: n=3 experiments. Each experiment was performed in triplicate.
Although the change was not statistically significant in the array, gene expression was assessed by qRT-PCR because of this gene’s pertinence to human pregnancy.